Lv1
34 积分 2022-09-18 加入
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study
1个月前
已完结
Interferon-ε is a tumour suppressor and restricts ovarian cancer
2个月前
已完结
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
2个月前
已完结
Measuring Piezo1 and Actin Polarity in Chemokine-Stimulated Jurkat Cells During Live-Cell Imaging
2个月前
已关闭
Promotion of DNA end resection by BRCA1–BARD1 in homologous recombination
2个月前
已完结
PIEZO1 mechanically regulates the antitumour cytotoxicity of T lymphocytes
3个月前
已完结
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
3个月前
已完结
Targeting Piezo1 unleashes innate immunity against cancer and infectious disease
3个月前
已完结
Laser‐Activatable In Situ Vaccine Enhances Cancer‐Immunity Cycle
4个月前
已完结
皖公网安备34019202002308
